Sevoflurane → Sevoflurane

HRID 15692

反応式

HRID 15692 の反応式
[CH2:1]([F:12])[O:2][CH:3]([C:8]([F:11])([F:10])[F:9])[C:4]([F:7])([F:6])[F:5]>O>[CH2:1]([F:12])[O:2][CH:3]([C:4]([F:7])([F:5])[F:6])[C:8]([F:9])([F:11])[F:10].[CH:3]([OH:2])([C:8]([F:11])([F:10])[F:9])[C:4]([F:7])([F:6])[F:5]

参加物

4

実験手順

The steps of combining the crude sevoflurane with water in an amount sufficient to produce a multiphase mixture comprising an aqueous phase and a sevoflurane phase, contacting the aqueous phase and the sevoflurane phase with each other under conditions and for a time sufficient to extract at least a portion of the HFIP from the sevoflurane phase into the aqueous phase, and separating the phases of the multiphase mixture without fractional distillation, may, if necessary, be repeated. Purified sevoflurane comprising an acceptable amount of HFIP is then isolated. The removal of HFIP from the crude sevoflurane occurs without contacting the crude sevoflurane with an aqueous basic solution.

後処理

  1. customto produce a multiphase mixture
  2. extractionthe sevoflurane phase with each other under conditions and for a time sufficient to extract at least a portion of the HFIP from the sevoflurane phase into the aqueous phase
  3. customseparating the phases of the multiphase mixture
  4. distillationwithout fractional distillation

出典と根拠

ORDレコード
ord-8af87598142a452492a12f735d884d3e
出典データセット
uspto-grants-2010_06
特許番号
US07732647B2

関連ノート

読み込み中…